EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

Evaluation of Homogentisic Acid, a Prospective Antibacterial Agent Highlighted by the Suitability of Nitisinone in Alkaptonuria 2 (SONIA 2) Clinical Trial

Nicola Ooi iD, Ian R Cooper, Brendan Norman iD, James A Gallagher, Nick Sireau, George Bou-Gharios, Lakshminarayan R Ranganath, Victoria J Savage iD

Cells · 2023

DOI: 10.3390/cells12131683 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Cells, 2023. Verfasst von Nicola Ooi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Infex Therapeutics, Alderley Park, Macclesfield SK10 4TG, UK. Hauptthemen laut MEDLINE: Alkaptonuria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Infection Innovation consortium (iiCON), National Alkaptonuria Centre, Liverpool University Hospitals, Strength In Places Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite urgent warnings about the spread of multidrug-resistant bacteria, the antibiotic development pipeline has remained sparsely populated. Naturally occurring antibacterial compounds may provide novel chemical starting points for antibiotic development programs and should be actively sought out. Evaluation of homogentisic acid (HGA), an intermediate in the tyrosine degradation pathway, showed that the compound had innate activity against Gram-positive and Gram-negative bacteria, which was lost following conversion into the degradation product benzoquinone acetic acid (BQA). Anti-staphylococcal activity of HGA can be attributed to effects on bacterial membranes. Despite an absence of haemolytic activity, the compound was cytotoxic to human HepG2 cells. We conclude that the antibacterial activity and in vitro safety profile of HGA render it more suitable for use as a topical agent or for inclusion in a small-molecule medicinal chemistry program.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlkaptonuriaHumansAnti-Bacterial AgentsGram-Negative BacteriaGram-Positive BacteriaHomogentisic AcidProspective StudiesCyclohexanonesNitrobenzoates

Stichwörter der Autor:innen

AKUalkaptonuriaantimicrobialbacteriahomogentisic acidmechanism of actionsafety

Substanzen

Anti-Bacterial AgentsHomogentisic AcidnitisinoneCyclohexanonesNitrobenzoates

Autor:innen und Institutionen

  • Infex Therapeutics, Alderley Park, Macclesfield SK10 4TG, UK.
  • Institute of Life Course and Medical Sciences, William Henry Duncan Building, University of Liverpool, Liverpool L7 8TX, UK.
  • AKU Society, Cambridge CB1 2BL, UK.
  • Departments of Clinical Biochemistry and Metabolic Medicine, Liverpool University Hospitals NHS Foundation Trusts, Liverpool L7 8XP, UK.

ORCID-Profile: Nicola Ooi, Brendan Norman, Victoria J Savage

Förderung

  • Infection Innovation consortium (iiCON)
  • National Alkaptonuria Centre, Liverpool University Hospitals
  • Strength In Places Fund

Zitieren

APA

Ooi, N., Cooper, I. R., Norman, B., Gallagher, J. A., Sireau, N., Bou-Gharios, G., Ranganath, L. R., & Savage, V. J. (2023). Evaluation of Homogentisic Acid, a Prospective Antibacterial Agent Highlighted by the Suitability of Nitisinone in Alkaptonuria 2 (SONIA 2) Clinical Trial. Cells. https://doi.org/10.3390/cells12131683

Vancouver

Ooi N, Cooper IR, Norman B, Gallagher JA, Sireau N, Bou-Gharios G, et al. Evaluation of Homogentisic Acid, a Prospective Antibacterial Agent Highlighted by the Suitability of Nitisinone in Alkaptonuria 2 (SONIA 2) Clinical Trial. Cells. 2023. doi:10.3390/cells12131683

BibTeX
@article{Ooi2023,
  author = {Ooi, Nicola and Cooper, Ian R and Norman, Brendan and Gallagher, James A and Sireau, Nick and Bou-Gharios, George and Ranganath, Lakshminarayan R and Savage, Victoria J},
  title = {Evaluation of Homogentisic Acid, a Prospective Antibacterial Agent Highlighted by the Suitability of Nitisinone in Alkaptonuria 2 (SONIA 2) Clinical Trial},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12131683}
}
Kostenlos starten →